Atossa Therapeutics, Inc. (ATOS)
0.7268
+0.01
(+1.69%)
USD |
NASDAQ |
Dec 16, 15:19
Atossa Therapeutics Research and Development Expense (Annual): 14.12M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Celldex Therapeutics, Inc. | 160.37M |
| Abeona Therapeutics, Inc. | 34.36M |
| Phibro Animal Health Corp. | 23.73M |
| Kiora Pharmaceuticals, Inc. | 7.842M |
| Intellia Therapeutics, Inc. | 456.03M |